Cargando…
Comment on “Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19”
Autores principales: | Dinoto, Alessandro, Cheli, Marta, Sartori, Arianna, Manganotti, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
British Epilepsy Association. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425771/ https://www.ncbi.nlm.nih.gov/pubmed/32827979 http://dx.doi.org/10.1016/j.seizure.2020.08.007 |
Ejemplares similares
-
Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19
por: Monti, Giulia, et al.
Publicado: (2020) -
Ketamine use in refractory status epilepticus associated with anti-NMDA receptor antibody encephalitis()
por: Santoro, Jonathan D., et al.
Publicado: (2019) -
Encephalitis with Anti-SOX1 Antibodies Presenting with New-Onset Refractory Status Epilepticus
por: Cho, Hee-Jin, et al.
Publicado: (2019) -
Refractory status epilepticus from NMDA receptor encephalitis successfully treated with an adjunctive ketogenic diet
por: Amer, Syed, et al.
Publicado: (2015) -
Anti-N-methyl D-aspartate receptor encephalitis presenting with the new-onset refractory status epilepticus
por: Alemdar, Murat, et al.
Publicado: (2023)